Pre-launch insight to Torx™, a new platform for small molecule discovery chemistry
Read full press release
Cambridge, UK – 26th April 2016 – Cresset, an innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that SAI Life Sciences, a CDMO service provider with headquarters in Hyderabad India, has licensed several Cresset molecular design tools to advance their customer projects.
“We are pleased to associate with Cresset and have licensed cresset tools (Torch with Activity Miner, Spark), as the best tools to help our medicinal chemists design and optimize new drug candidates for our innovator clients,” says Sarma BVNBS, Vice President of Medicinal Chemistry at SAI Life Sciences. “We will be using Torch and Activity Miner to gain new insights into our SAR data, while Spark will help us to identify novel scaffolds and to make bioisosteric core replacements. We look forward to developing our relationship with Cresset and enhancing the success of our client programs through the combination of our skills and competences.”
Dr David Bardsley, Commercial Director at Cresset, says, “We are delighted that SAI Life Sciences has chosen Cresset tools to form part of their state of the art medicinal chemistry and discovery services. As more and more pharmaceutical innovator companies choose to outsource to SAI we look forward to helping them deliver successful NCE candidates for their customers.”